Related references
Note: Only part of the references are listed.Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis
Shyam Sundar et al.
TheScientificWorldJOURNAL (2015)
Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis
Shyam Sundar et al.
Scientific World Journal (2015)
Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis
A. C. Vallur et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial
Shyam Sundar et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis
Thomas P. C. Dorlo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Arsenic in tube well water in Bangladesh: health and economic impacts and implications for arsenic mitigation
Sara V. Flanagan et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2012)
Miltefosine as an effective choice in the treatment of post-kala-azar dermal leishmaniasis
V. Ramesh et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Recent advances in post-kala-azar dermal leishmaniasis
Dinesh Mondal et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
CUMULATIVE CARDIAC TOXICITY OF SODIUM STIBOGLUCONATE AND AMPHOTERICIN B IN TREATMENT OF KALA-AZAR
Anu Maheshwari et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Increasing Incidence of Post-Kala-Azar Dermal Leishmaniasis in a Population-Based Study in Bangladesh
Kazi Mizanur Rahman et al.
CLINICAL INFECTIOUS DISEASES (2010)
Oral miltefosine in post-kala-azar dermal leishmaniasis - experience in three cases
Sujay Khandpur et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2010)
Interleukin 10 Gene Polymorphisms and Development of Post Kala-Azar Dermal Leishmaniasis in a Selected Sudanese Population
S. Farouk et al.
PUBLIC HEALTH GENOMICS (2010)
Status of groundwater arsenic contamination in Bangladesh: A 14-year study report
Dipankar Chakraborti et al.
WATER RESEARCH (2010)
Enhanced Case Detection and Improved Diagnosis of PKDL in a Kala-azar-Endemic Area of Bangladesh
Dinesh Mondal et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Immunochemotherapy of persistent post-kata-azar dermal leishmaniasis: a novel approach to treatment
Ahmed Mudawi Musa et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
IL-10- and TGF-β-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis:: The significance of amphotericin B in the control of Leishmania donovani infection in India
Samiran Saha et al.
JOURNAL OF IMMUNOLOGY (2007)
Hypocholesterolemia and increased triglyceride in pediatric visceral leishmaniasis
Chandra S. Lal et al.
CLINICA CHIMICA ACTA (2007)
IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan
M. A. Salih et al.
GENES AND IMMUNITY (2007)
Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine
Shyam Sundar et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Successful miltefosine treatment of post-kala-azar dermal leishmaniasis occurring during antiretroviral therapy
AD Belay et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2006)
Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients
R Vijayaraghavan et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2005)
Interferon-γ and interleukin-10 gene polymorphisms in pulmonary tuberculosis
D López-Maderuelo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Post-kala-azar dermal leishmaniasis
EE Zijistra et al.
LANCET INFECTIOUS DISEASES (2003)
Share Paper
